GlobalData's clinical trial report, "Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2012" provides data on the Cytomegalovirus (HHV-5) Infections/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (HHV-5) Infections/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cytomegalovirus (HHV-5) Infections/Impaired Glucose Tolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords:
Cytomegalovirus (HHV-5) Infections/Impaired Glucose Tolerance Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Cytomegalovirus (HHV-5) Infections/Impaired Glucose Tolerance, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Cytomegalovirus (HHV-5) Infections
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Cytomegalovirus (HHV-5) Infections
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Cell Medica Limited
Clinical Trial Overview of Cell Medica Limited
Isis Pharmaceuticals, Inc.
Clinical Trial Overview of Isis Pharmaceuticals, Inc.
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
ViroPharma Incorporated
Clinical Trial Overview of ViroPharma Incorporated
AiCuris GmbH & Co. KG
Clinical Trial Overview of AiCuris GmbH & Co. KG
Roche Global Development
Clinical Trial Overview of Roche Global Development
Stage Pharmaceuticals GmbH
Clinical Trial Overview of Stage Pharmaceuticals GmbH
Microbiotix, Inc.
Clinical Trial Overview of Microbiotix, Inc.
Theraclone Sciences, Inc.
Clinical Trial Overview of Theraclone Sciences, Inc.
AlphaVax, Inc.
Clinical Trial Overview of AlphaVax, Inc.
Sandoz Inc.
Clinical Trial Overview of Sandoz Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Vical Incorporated
Clinical Trial Overview of Vical Incorporated
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Baylor College of Medicine
Clinical Trial Overview of Baylor College of Medicine
Clinical Trial Overview of
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
University of Alabama at Birmingham
Clinical Trial Overview of University of Alabama at Birmingham
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of Pennsylvania
Clinical Trial Overview of University of Pennsylvania
Kobe University
Clinical Trial Overview of Kobe University
University Hospital, Limoges
Clinical Trial Overview of University Hospital, Limoges
Virginia Commonwealth University
Clinical Trial Overview of Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Queensland Institute of Medical Research
Clinical Trial Overview of Queensland Institute of Medical Research
Chongqing Medical University
Clinical Trial Overview of Chongqing Medical University
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Imperial College London
Clinical Trial Overview of Imperial College London
University of Massachusetts
Clinical Trial Overview of University of Massachusetts
Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2012 published by GlobalData in June 30, 2012. This report consists of Pages: 101 and the price starts from US $ 2500.
